THUSHARA CARLYON
Davie, FL ***** 973-***-**** adylyr@r.postjobfree.com
Professional Summary
Regulatory Medical Writer with 18 years of experience in writing regulatory clinical documents, managing and planning of US and European health authority submissions for new molecular entities
(NMEs) and biologic license applications (BLAs).
Skills
Motivational Leadership
Plan Projects
Team Leadership
Collaborate Cross-Functionally
Work History
Associate Director 01/2019 to 01/2021
Sarepta Therapeutics
Submission planning; created and managed MW timelines and dossier strategy for the NDA submission and report production
Managed medical writers (contract), and authored integrated summaries of safety, briefing packages for pre-NDA submission meetings, clinical study reports, high level summaries such as Safety (eCTD 2.7.4), and Clinical Overviews (eCTD 2.5) to completed NDA filings Authored protocol amendments
Reviewed and provided feedback on statistical analysis plans and prototype data displays for high level summaries and clinical study reports.
Independent Regulatory Medical Writer 01/2017 to 01/2018 Carlyon Writing LLC
Wrote briefing packages for pre-NDA submission meetings, Clinical Study Reports, Summaries for Clinical Efficacy (2.7.3), Safety (2.7.4), and clinical overviews (2.5) for NDA filings Wrote 3 Phase 1
Protocols.
Principal Medical Writer 01/2013 to 01/2017
Allergan Inc
Managed medical writers, created dossier strategy and authored integrated summaries of efficacy, safety, briefing packages for pre-NDA submission meetings, end of phase 2 meetings, clinical study reports (phase 1 and 3), high level summaries such as Summaries for Clinical Pharmacology, (eCTD 2.7.2)
Efficacy (eCTD 2.7.3), Safety (eCTD 2.7.4), Biopharmaceutics (eCTD 2.7.1) and Clinical Overviews
(eCTD 2.5) for completed NDA filings
Authored clinical sections of INDs including the general investigation plan, phase 3 protocols, abstracts, publications and posters for data resulting from clinical studies Submission planning; created and managed timelines for submissions and report production Reviewed and provided feedback on statistical analysis plans and prototype data displays for high level summaries and clinical study reports.
Independent Regulatory Medical Writer 01/2011 to 01/2013 Carlyon Writing LLC
Wrote briefing packages for pre-NDA submission meeting, advisory committee meetings, end of phase 2 meetings, CSRs, Summaries for Clinical Pharmacology, (2.7.2) Efficacy (2.7.3), Safety
(2.7.4),
Biopharmaceutics (2.7.1) and clinical overviews (2.5) for 3 completed NDA filings Therapeutic areas: oncology, dermatology, cardiovascular (anti-coagulation) and medical devices
Authored protocols for
Phase 1 studies in Alzheimer's and Schizophrenia.
International Document Manager 01/2008 to 01/2011
Roche Pharmaceuticals
Managed medical writers as the lead writer to provide strategy and mentoring in therapeutic areas of oncology, virology and metabolism
Submission planning; created and managed timelines for submissions and report production Created dossier strategy and authored high level summaries such as leCTD 2.7.3 and Safety
(eCTD 2.7.4), and clinical overviews (eCTD 2.5), briefing packages, clinical study reports (phase 1 to 3) for new biologics for FDA and Marketing Applications and Type II variations for EMA
Authored 4-month safety updates and the responses to health authority questions Reviewed and provided feedback on statistical analysis plans and prototype data displays for high level summaries and
CSRs.
Education
Ph.D: Animal Sciences/Protein Biochemistry
Rutgers University - New Brunswick, NJ
M.S: Animal Sciences/Parasitology
Rutgers University - New Brunswick, NJ
B.S: Agricultural Science
Rutgers University - New Brunswick, NJ
Accomplishments
Suresh Sikka, PhD, HCLD, CC (ABB), Thushara Carlyon PhD; Lara Cardinali MS; Vilma Sniukiene MD; Tina deVries, PhD
An evaluation of semen characteristics in men after daily dosing of Udenafil Sexual
Medicines Society of North America, November, 2014
(Poster)
David Portman, MD; Thushara Carlyon, PhD; Heather Thomas, PhD; Kathleen Reape, MD FACOG Efficacy and safety of a new low-dose estradiol vaginal cream administered twice a week for the treatment of vaginal dryness associated with menopause North American Menopause Society, October, 2014
(Poster)
Robin Kroll, MD; Thushara Carlyon, PhD; Heather Thomas, PhD; Kathleen Reape, MD FACOG Efficacy and
Safety of a New Low-Dose Estradiol Vaginal Cream Administered 3 Times a Week for the Treatment of
Dyspareunia Associated with Menopause
North American Menopause Society, October, 2014
(Poster)